Johannes Eggert

Title: The Innovative Contributions of Johannes Eggert

Introduction

Johannes Eggert is a notable inventor based in Usingen, Germany. He has made significant contributions to the field of chemistry, particularly in the preparation of triazole compounds. His work has implications for various applications in pharmaceuticals and beyond.

Latest Patents

Johannes Eggert holds a patent for a method for the preparation of triazole compounds. This patent details a process for preparing 1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1H-1,2,3-triazol-1-yl)-1H-pyrazol-5-ol (enol form) and 2-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1H-1,2,3-triazol-1-yl)-1,2-dihydro-3H-pyrazol-3-one (keto form). The process involves several key reagents, including 1,2,3-triazole, methyl bromoacetate, ethyl bromoacetate, 4,6-dichloropyrimidine, morpholine, and hydrazine. He has been granted 1 patent for this innovative method.

Career Highlights

Johannes Eggert is currently employed at Bayer Pharma Aktiengesellschaft, a leading company in the pharmaceutical industry. His role involves research and development, where he applies his expertise in chemistry to advance the company's product offerings. His work is instrumental in driving innovation within the organization.

Collaborations

Johannes collaborates with Hans-Christian Militzer, a fellow researcher at Bayer Pharma Aktiengesellschaft. Together, they work on various projects that aim to enhance the understanding and application of triazole compounds in medicinal chemistry.

Conclusion

Johannes Eggert's contributions to the field of chemistry, particularly through his patent on triazole compounds, highlight his innovative spirit and dedication to advancing pharmaceutical research. His work continues to impact the industry positively.